Investment
Investment

Team

Plasma for People

Miroslav Mašata

CEO, Founder

  • Represented 20 Czech and Slovak manufacturers in the healthcare sector in the Middle East and Africa
  • Participated in the preparation of feasibility studies for the construction of hospitals in the region
  • Mirek is the main holder of all know-how and majority shareholder of the technology for the production of blood plasma substitute

Associate Professor Irena Šlamborová, Ph.D.

Patent author

  • Author of a patent for a blood plasma substitute

  • Leading expert on research into the use of nanomaterials in medical practice
  • Irena is responsible for leading the research work in the development of our project

Pavel Kubů, MD.

Chief Medical Officer

  • Leading expert on the use of cannabis products in medical practice
  • Advisor to the National Drug Coordinator for Digitalisation
  • Pavel is responsible for the clinical side of this project

Miroslava Masaříková

Fundraising

  • Founder of the A4F platform
  • Miroslava is mainly responsible for fundraising activities for P4P

Karolína Mladějovská

Marketing & Social Media

  • Karolína is responsible for social media management, from concept to final post
  • Her work includes content creation, video editing, and graphic design

Associate Professor Tomáš Vontor, PharmD, Eng., CSc.

Expert guarantor

  • He was engaged in research and development of new drugs including GMP (Good Manufacturing Practice)
  • He has worked for a number of pharmaceutical companies in the Czech Republic, USA, Italy and Slovakia
  • He is an expert guarantor of the project

"Edestin as an organic substitute for blood albumin opens up a wealth of possibilities in therapeutic applications."